Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 1, 2007 - Issue 4
Journal homepage
47
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of biomarkers in the diagnosis of inflammatory bowel disease

Severine Vermeire University Hospital Leuven, Department of Gastroenterology, Herestraat 49, 3000 Leuven, Belgium +32 16 34 42 25; +32 16 34 43 99; [email protected]
, MD PhD (Assistant Professor of Medicine) ,
Gert Van Assche University Hospital Leuven, Department of Gastroenterology, Herestraat 49, 3000 Leuven, Belgium +32 16 34 42 25; +32 16 34 43 99; [email protected]
, MD PhD (Associate Professor of Medicine) &
Paul Rutgeerts University Hospital Leuven, Department of Gastroenterology, Herestraat 49, 3000 Leuven, Belgium +32 16 34 42 25; +32 16 34 43 99; [email protected]
, MD PhD FRCP (Professor of Medicine)
Pages 481-488 | Published online: 29 Nov 2007

Bibliography

  • BALLOU SP, KUSHNER I: C-reactive protein and the acute phase response. Adv. Intern. Med. (1992) 37:313-336.
  • GABAY C, KUSHNER I: Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. (1999) 340:448-454.
  • PEPYS MB: C-reactive protein fifty years on. Lancet (1981) 1:653-657.
  • FAGAN EA, DYCK RF, MATON PN et al.: Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur. J. Clin. Invest. (1982) 12:351-359.
  • NIEDERAU C, BACKMERHOFF F, SCHUMACHER B, NIEDERAU C: Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepatogastroenterology (1997) 44:90-107.
  • SAVERYMUTTU SH, HODGSON HJ, CHADWICK VS, PEPYS MB: Differing acute phase responses in Crohn's disease and ulcerative colitis. Gut (1986) 27:809-813.
  • SOLEM CA, LOFTUS EV Jr, TREMAINE WJ et al.: Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm. Bowel Dis. (2005) 11:707-712.
  • GROSS V, ANDUS T, CAESAR I, ROTH M, SCHOLMERICH J: Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 102:514-519.
  • CARLSON CS, ALDRED SF, LEE PK et al.: Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. (2005) 77:64-77.
  • RUSSELL AI, CUNNINGHAME GRAHAM DS, SHEPHERD C et al.: Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum. Mol. Genet. (2004) 13:137-147.
  • THALMAIER D, DAMBACHER J, SEIDERER J et al.: The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment. Pharmacol. Ther. (2006) 24:1105-1115.
  • SZALAI AJ, MCCRORY MA, COOPER GS, WU J, KIMBERLY RP: Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun. (2002) 3:14-19.
  • KOZLOWSKI P, MILLER DT, ZEE RY et al.: Lack of association between genetic variation in 9 innate immunity genes and baseline CRP levels. Ann. Hum. Genet. (2006) 70(Part 5):574-586.
  • WILLOT S, VERMEIRE S, OHRESSER M et al.: No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease. Pharmacogenet. Genomics (2006) 16:37-42.
  • POULLIS AP, ZAR S, SUNDARAM KK et al.: A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur. J. Gastroenterol. Hepatol. (2002) 14:409-412.
  • ZILBERMAN L, MAHARSHAK N, ARBEL Y et al.: Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis. Digestion (2006) 73:205-209.
  • OSEI-BIMPONG A, MEEK JH, LEWIS SM: ESR or CRP? A comparison of their clinical utility. Hematology (2007) 12:353-357.
  • BJERRUM OW, NISSEN MH, BORREGAARD N: Neutrophil beta-2 microglobulin: an inflammatory mediator: Scand. J. Immunol. (1990) 32:233-242.
  • JENSEN KB, JARNUM S, KOUDAHL G, KRISTENSEN M: Serum orosomucoid in ulcerative colitis: its relation to clinical activity, protein loss, and turnover of albumin and IgG. Scand. J. Gastroenterol. (1976) 11:177-183.
  • CONSIGNY Y, MODIGLIANI R, COLOMBEL JF et al.; GROUPE D'ETUDES THÉRAPEUTIQUES DES AFFECTIONS INFLAMMATOIRES DIGESTIVES (GETAID): A simple biological score for predicting low risk of short-term relapse in Crohn's disease. Inflamm. Bowel Dis. (2006) 12:551-557.
  • FLORIN TH, PATERSON EW, FOWLER EV, RADFORD-SMITH GL: Clinically active Crohn's disease in the presence of a low C-reactive protein. Scand. J. Gastroenterol. (2006) 41:306-311.
  • DENIS MA, REENAERS C, FONTAINE F, BELAÏCHE J, LOUIS E: Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm. Bowel Dis. (2007) 13:1100-1105.
  • LANDERS CJ, COHAVY O, MISRA R et al.: Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology (2002) 123:689-699.
  • TARGAN SR, LANDERS CJ, YANG H et al.: Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology (2005) 128:2020-2028.
  • DOTAN I, FISHMAN S, DGANI Y et al.: Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology (2006) 131:366-378.
  • TERJUNG B, SPENGLER U, SAUERBRUCH T, WORMAN HJ: ‘Atypical p-ANCA’ in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology (2000) 119:310-322.
  • MOW WS, VASILIAUSKAS EA, LIN YC et al.: Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology (2004) 126:414-424.
  • FERRANTE M, HENCKAERTS L, JOOSSENS M et al.: New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut (2007) [Epub ahead of print].
  • PAPP M, ALTORJAY I, NORMAN GL et al.: Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm. Bowel Dis. (2007) 13:984-992.
  • PATEL RT, STOKES R, BIRCH D, IBBOTSON J, KEIGHLEY MR: Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br. J. Surg. (1994) 81:724-726.
  • KUISMA J, JÄRVINEN H, KAHRI A, FÄRKKILÄ M: Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand. J. Gastroenterol. (2004) 39:544-548.
  • FLESHNER PR, VASILIAUSKAS EA, KAM LY et al.: High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut (2001) 49(5):671-677.
  • AISENBERG J, LEGNANI PE, NILUBOL N et al.: Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. (2004) 99(3):432-441.
  • FERRANTE M, DECLERCK S, PENNINCKX F et al.: Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. JCC (In Press).
  • DUBINSKY MC, OFMAN JJ, URMAN M, TARGAN SR, SEIDMAN EG: Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am. J. Gastroenterol. (2001) 96:758-765.
  • JOOSSENS S, REINISCH W, VERMEIRE S et al.: The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology (2002) 122:1242-1247.
  • JOOSSENS S, COLOMBEL JF, LANDERS C et al.: Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut (2006) 55:1667-1669.
  • ISRAELI E, GROTTO I, GILBURD B et al.: Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 54:1232-1236.
  • DEVLIN SM, YANG H, IPPOLITI A et al.: NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology (2007) 132:576-586.
  • HENCKAERTS LC, PIERIK M, JOOSSENS M, FERRANTE M, RUTGEERTS PJ, VERMEIRE S: Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut (2007) 56(11):1536-1542.
  • ANGRIMAN I, SCARPA M, D'INCÀ R et al.: Enzymes in feces: useful markers of chronic inflammatory bowel disease. Clin. Chim. Acta (2007) 381:63-68.
  • WALKER TR, LAND ML, KARTASHOV A et al.: Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. (2007) 44:414-422.
  • LANGHORST J, ELSENBRUCH S, MUELLER T et al.: Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm. Bowel Dis. (2005) 11:1085-1091.
  • LUNDBERG JO, HELLSTRÖM PM, FAGERHOL MK, WEITZBERG E, ROSETH AG: Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol. (2005) 2:96-102.
  • SUGI K, SAITOH O, HIRATA I, KATSU K: Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am. J. Gastroenterol. (1996) 91:927-934.
  • TIBBLE JA, SIGTHORSSON G, FOSTER R et al.: High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut (1999) 45:362-366.
  • ROSETH AG, SCHMIDT PN, FAGERHOL MK: Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand. J. Gastroenterol. (1999) 34:50-54.
  • FAGERBERG UL, LOOF L, MYRDAL U, HANSSON LO, FINKEL Y: Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J. Pediatr. Gastroenterol. Nutr. (2005) 40:450-455.
  • RØSETH AG, AADLAND E, GRZYB K: Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand. J. Gastroenterol. (2004) 39:1017-1020.
  • THJODLEIFSSON B, SIGTHORSSON G, CARIGLIA N et al.: Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology (2003) 124:1728-1737.
  • DE JONG NS, LEACH ST, DAY AS: Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm. Bowel Dis. (2006) 12:566-572.
  • KAISER T, LANGHORST J, WITTKOWSKI H et al.: Fecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 56(12):1706-1713.
  • SCHOEPFER AM, TRUMMLER M, SEEHOLZER P, SEIBOLD-SCHMID B, SEIBOLD F: Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm. Bowel Dis. (2007) (In Press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.